The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(1R,4S,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-N-octylcyclohex-2-enaminium chloride ID: ALA1922579
PubChem CID: 11359212
Max Phase: Preclinical
Molecular Formula: C15H30ClNO4
Molecular Weight: 287.40
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCCCCCCCN[C@@H]1C=C(CO)[C@H](O)[C@H](O)[C@H]1O.Cl
Standard InChI: InChI=1S/C15H29NO4.ClH/c1-2-3-4-5-6-7-8-16-12-9-11(10-17)13(18)15(20)14(12)19;/h9,12-20H,2-8,10H2,1H3;1H/t12-,13+,14+,15+;/m1./s1
Standard InChI Key: MPYFYLDLOZTRGL-SJFOYXCYSA-N
Molfile:
RDKit 2D
21 20 0 0 0 0 0 0 0 0999 V2000
-1.2208 0.3750 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-3.5792 0.4292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5792 -0.3958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8671 -0.8042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1551 -0.3958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1551 0.4292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8671 0.8458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8671 1.6708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1527 2.0833 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.2948 0.8396 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.2930 -0.8094 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.8671 -1.6292 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.4413 -0.8094 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.7262 -0.3979 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0123 -0.8114 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7028 -0.4000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4166 -0.8135 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1317 -0.4021 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8456 -0.8156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5606 -0.4041 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2745 -0.8177 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3 11 1 1
3 4 1 0
4 12 1 6
4 5 1 0
5 13 1 1
5 6 1 0
13 14 1 0
6 7 2 0
14 15 1 0
15 16 1 0
7 8 1 0
16 17 1 0
17 18 1 0
8 9 1 0
18 19 1 0
2 3 1 0
19 20 1 0
2 10 1 1
20 21 1 0
2 7 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 287.40Molecular Weight (Monoisotopic): 287.2097AlogP: 0.32#Rotatable Bonds: 9Polar Surface Area: 92.95Molecular Species: NEUTRALHBA: 5HBD: 5#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 5#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.83CX Basic pKa: 8.47CX LogP: 0.40CX LogD: -0.70Aromatic Rings: ┄Heavy Atoms: 20QED Weighted: 0.31Np Likeness Score: 1.50
References 1. Kuno S, Takahashi A, Ogawa S.. (2011) Transformation of quercitols into 4-methylenecyclohex-5-ene-1,2,3-triol derivatives, precursors for the chemical chaperones N-octyl-4-epi-β-valienamine (NOEV) and N-octyl-β-valienamine (NOV)., 21 (23): [PMID:22001090 ] [10.1016/j.bmcl.2011.09.067 ] 2. Kuno S, Higaki K, Takahashi A, Nanba E, Ogawa S. (2015) Potent chemical chaperone compounds for GM1-gangliosidosis: N-substituted (+)-conduramine F-4 derivatives, 6 (2): [10.1039/C4MD00270A ]